/Home/Greater China Region/Life Sciences (International Firms) in China/Paul Hastings LLP
View profile of Paul Hastings LLP
Department profile
Paul Hastings LLP
Department profile | Paul Hastings LLP
Life Sciences (International Firms)

Chambers Review

Provided by Chambers

Life Sciences (International Firms) - China

4
Band 4

What the Team is Known For

Paul Hasting is growing its presence in the life sciences and healthcare space with a noteworthy track record of assisting pharmaceutical companies with internal and governmental investigations, ABAC compliance and risk assessments. The firm's transactional capability is sought after by pharmaceutical companies and investors to handle acquisitions and investments. It also swiftly deals with disputes over licensing agreements and shareholder agreements. Additionally, the team is also adept at data privacy and cybersecurity compliance.

Notable practitioners

Shaun Wu is a key client contact.

Work Highlights

  • Paul Hastings advised China International Capital Corporation Hong Kong Securities and relevant parties on the USD38.67 million global offering and listing of PegBio on the Main Board of the Hong Kong Stock Exchange.

Strengths

Provided by Chambers

The team has expertise in the China healthcare market and practices. It is very responsive to my outreach and requests of all kinds and has intimate knowledge of the company's business.

Life Sciences (International Firms) respondent
Greater China Region

Paul Hastings possesses a good ability to dissect detailed facts and make recommendations accordingly.

Life Sciences (International Firms) respondent
Greater China Region